Biosimilar Infliximab Utilization After Patent Expiry- The Case of Colitis Ulcerosa and Rheumatoid Arthritis in Hungary
May 1, 2018, 00:00
10.1016/j.jval.2018.04.643
https://www.valueinhealthjournal.com/article/S1098-3015(18)30943-4/fulltext
Title :
Biosimilar Infliximab Utilization After Patent Expiry- The Case of Colitis Ulcerosa and Rheumatoid Arthritis in Hungary
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30943-4&doi=10.1016/j.jval.2018.04.643
First page :
Section Title :
Open access? :
No
Section Order :
1432